Neurobiological Basis and Pharmacologic Treatment of Social Impairment in Autism Spectrum Disorders

Publisher： Bentham Science Publishers

E-ISSN： 2211-5579|1|3|233-246

ISSN： 2211-5560

Source： Current Psychopharmacology, Vol.1, Iss.3, 2012-01, pp. : 233-246

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neurobiological Basis and Pharmacologic Treatment of Social Impairment in Autism Spectrum Disorders

By Yui K.   Koshiba M.   Nakamura S.  

Current Psychopharmacology, Vol. 1, Iss. 3, 2012-08 ,pp. : 233-246

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of Adding Large Doses of Arachidonic Acid to Docosahexaenoic Acid on Social Impairment in Individuals with Autism Spectrum Disorders

By Yui K.   Koshiba K.   Nakamura S.  

Current Psychopharmacology, Vol. 2, Iss. 1, 2013-02 ,pp. : 84-90

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of Adding Large Doses of Arachidonic Acid to Docosahexaenoic Acid on Social Impairment in Individuals with Autism Spectrum Disorders

By  

Current Psychopharmacology, Vol. 2, Iss. 1, 2013-02 ,pp. : 84-90

Bentham Science Publishers

Access to resources Recommend Favorite

Melatonin in Autism Spectrum Disorders

By  

Current Clinical Pharmacology, Vol. 9, Iss. 4, 2014-11 ,pp. : 326-334

Bentham Science Publishers

Access to resources Recommend Favorite

New directions in the treatment of autism spectrum disorders from animal model research

By Chadman Kathryn K   Guariglia Sara R   Yoo Jiyeon Helen  

Expert Opinion on Drug Discovery, Vol. 7, Iss. 5, 2012-05 ,pp. : 407-416

Informa Healthcare

Access to resources Recommend Favorite